Monday, July 10, 2017 9:12:59 AM
ANTH - 1.55 Pre-market now at 1.62/1.64
Anthera Pharma Jumps 10% After Co Says Phase 3 Clinical Sollpura Study to be Included in Cystic Fibrosis Foundation Therapeutics Development Network
Anthera Pharma Jumps 10% After Co Says Phase 3 Clinical Sollpura Study to be Included in Cystic Fibrosis Foundation Therapeutics Development Network
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
